Physician

John Kerrison, M.D.

According to 2025 Medicare claims, John Kerrison, M.D. (NPI: 1952416257) practices ophthalmology in the Charleston-North Charleston, SC market, with the plurality of this provider's patient population coming from Charleston, SC. This provider's primary affiliated billing organization is CHARLESTON NEUROSCIENCES INSTITUTE (NPI: 1225094600; TIN: 202359956) and primary practice location at 29414-5896.

Kerrison's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,423 traditional Medicare patients, billed 38,534 HCPCS/CPT codes, and received $5,738,929 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 3,678 prescription claims across 587 beneficiaries totaling $162,674 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 68 records totaling $217,531. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,122,112 to $5,738,929. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.0M$6.0M2015 Medicare payment: $1,122,112 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,187,240 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,308,828 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $6,024,136 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,474,190 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,936,426 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,538,765 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,542,119 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,057,435 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,738,929 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,73217,247$1,122,112
20161,85115,635$1,187,240
20171,82016,843$2,308,828
20181,78329,269$6,024,136
20191,90728,678$5,474,190
20201,65226,117$4,936,426
20211,51524,972$4,538,765
20221,54520,392$4,542,119
20231,45826,380$5,057,435
20241,42338,534$5,738,929

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$132K$264K2015 Drug cost: $129,532 (USD; Tot_Drug_Cst)2016 Drug cost: $156,370 (USD; Tot_Drug_Cst)2017 Drug cost: $263,899 (USD; Tot_Drug_Cst)2018 Drug cost: $201,827 (USD; Tot_Drug_Cst)2019 Drug cost: $227,455 (USD; Tot_Drug_Cst)2020 Drug cost: $232,454 (USD; Tot_Drug_Cst)2021 Drug cost: $207,177 (USD; Tot_Drug_Cst)2022 Drug cost: $207,863 (USD; Tot_Drug_Cst)2023 Drug cost: $217,296 (USD; Tot_Drug_Cst)2024 Drug cost: $162,674 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154952,590$129,532
20165233,007$156,370
20175183,294$263,899
20185763,500$201,827
20195863,661$227,455
20205763,351$232,454
20216043,440$207,177
20225883,374$207,863
20235763,618$217,296
20245873,678$162,674

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye4552,869$99
92014Established patient complete exam of visual system575693$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more382539$72
92012Established patient problem focused exam of visual system6071,021$59
92134Imaging of retina1,2083,924$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate72524,872$34,324
LumiganBimatoprost432,127$22,225
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol893,300$13,044
LatanoprostLatanoprost1,01255,695$10,577
RocklatanNetarsudil Mesylat/Latanoprost27758$9,693

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$692Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.44$216,839Kyowa Kirin, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Kerrison, M.D.?

Tedicare shows public-source Medicare data for John Kerrison, M.D. (NPI 1952416257), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Kerrison, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Kerrison, M.D.?

John Kerrison, M.D. is linked to CHARLESTON NEUROSCIENCES INSTITUTE (billing NPI 1225094600) in the available physician profile data.

Does John Kerrison, M.D. have Open Payments data?

John Kerrison, M.D. has 68 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.